This company has been marked as potentially delisted and may not be actively trading. OmniLit Acquisition (OLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock OLIT vs. CLIR, DAIO, MSAI, STAI, PRPO, BNGO, ASTC, TLIS, AXDX, and TBIOShould you be buying OmniLit Acquisition stock or one of its competitors? The main competitors of OmniLit Acquisition include ClearSign Technologies (CLIR), Data I/O (DAIO), MultiSensor AI (MSAI), Scantech AI Systems (STAI), Precipio (PRPO), Bionano Genomics (BNGO), Astrotech (ASTC), Talis Biomedical (TLIS), Accelerate Diagnostics (AXDX), and Telesis Bio (TBIO). These companies are all part of the "measuring and control equipment" industry. OmniLit Acquisition vs. Its Competitors ClearSign Technologies Data I/O MultiSensor AI Scantech AI Systems Precipio Bionano Genomics Astrotech Talis Biomedical Accelerate Diagnostics Telesis Bio OmniLit Acquisition (NASDAQ:OLIT) and ClearSign Technologies (NASDAQ:CLIR) are both small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment. Do institutionals & insiders have more ownership in OLIT or CLIR? 21.6% of OmniLit Acquisition shares are held by institutional investors. Comparatively, 24.0% of ClearSign Technologies shares are held by institutional investors. 78.0% of OmniLit Acquisition shares are held by company insiders. Comparatively, 16.9% of ClearSign Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better earnings and valuation, OLIT or CLIR? OmniLit Acquisition has higher earnings, but lower revenue than ClearSign Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmniLit AcquisitionN/AN/AN/AN/AN/AClearSign Technologies$2.90M10.87-$5.19M-$0.12-5.00 Do analysts recommend OLIT or CLIR? ClearSign Technologies has a consensus target price of $2.00, indicating a potential upside of 233.28%. Given ClearSign Technologies' stronger consensus rating and higher possible upside, analysts plainly believe ClearSign Technologies is more favorable than OmniLit Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniLit Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ClearSign Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to OLIT or CLIR? In the previous week, ClearSign Technologies had 1 more articles in the media than OmniLit Acquisition. MarketBeat recorded 1 mentions for ClearSign Technologies and 0 mentions for OmniLit Acquisition. ClearSign Technologies' average media sentiment score of 1.89 beat OmniLit Acquisition's score of 0.00 indicating that ClearSign Technologies is being referred to more favorably in the news media. Company Overall Sentiment OmniLit Acquisition Neutral ClearSign Technologies Very Positive Does the MarketBeat Community favor OLIT or CLIR? ClearSign Technologies received 153 more outperform votes than OmniLit Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformOmniLit AcquisitionN/AN/AClearSign TechnologiesOutperform Votes15340.58% Underperform Votes22459.42% Is OLIT or CLIR more profitable? OmniLit Acquisition has a net margin of 0.00% compared to ClearSign Technologies' net margin of -118.93%. OmniLit Acquisition's return on equity of 0.00% beat ClearSign Technologies' return on equity.Company Net Margins Return on Equity Return on Assets OmniLit AcquisitionN/A N/A N/A ClearSign Technologies -118.93%-50.44%-41.41% Which has more volatility and risk, OLIT or CLIR? OmniLit Acquisition has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500. Comparatively, ClearSign Technologies has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. SummaryClearSign Technologies beats OmniLit Acquisition on 9 of the 13 factors compared between the two stocks. Get OmniLit Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for OLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OLIT vs. The Competition Export to ExcelMetricOmniLit AcquisitionHolding Offices Industry SectorNASDAQ ExchangeMarket Cap$8.41M$485.32M$2.55B$8.50BDividend YieldN/A7.68%13.02%4.17%P/E RatioN/A2.5011.6819.66Price / SalesN/A80.163,130,852.87152.07Price / CashN/A69.0161.1334.64Price / BookN/A6.283.764.59Net IncomeN/A$35.76M-$466.93M$248.23M OmniLit Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OLITOmniLit AcquisitionN/A$1.37-8.7%N/A-50.0%$8.41MN/A0.003Gap DownCLIRClearSign Technologies3.0402 of 5 stars$0.66+1.7%$2.00+203.0%-16.7%$34.60M$2.90M-6.0010Positive NewsDAIOData I/O2.1636 of 5 stars$2.76-1.4%$4.00+44.9%+1.4%$25.50M$21.85M-14.53100News CoverageMSAIMultiSensor AI3.6844 of 5 stars$0.76-3.5%$2.50+230.0%-68.2%$25.33M$6.30M0.0035Short Interest ↓Gap DownSTAIScantech AI SystemsN/A$0.78+1.3%N/AN/A$19.95M$542.17K0.00N/APRPOPrecipio1.5533 of 5 stars$11.20-1.5%N/A+85.8%$16.93M$20.03M-6.1260Positive NewsShort Interest ↓Gap DownBNGOBionano Genomics1.5246 of 5 stars$3.75+1.9%$7.00+86.7%-92.7%$12.62M$28.46M-0.03300Positive NewsASTCAstrotech0.5599 of 5 stars$5.78+0.4%N/A-39.4%$9.78M$903K-0.7110Short Interest ↑Gap UpTLISTalis BiomedicalN/A$1.40flatN/AN/A$2.55M$300K-0.05260AXDXAccelerate Diagnostics0.9072 of 5 starsN/AN/AN/A$857K$11.70M-0.01220Gap DownHigh Trading VolumeTBIOTelesis Bio1.6102 of 5 stars$0.05flatN/A-99.0%$90K$225.09M0.00200Short Interest ↓ Related Companies and Tools Related Companies CLIR Alternatives DAIO Alternatives MSAI Alternatives STAI Alternatives PRPO Alternatives BNGO Alternatives ASTC Alternatives TLIS Alternatives AXDX Alternatives TBIO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OLIT) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OmniLit Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OmniLit Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
